AUSTIN, TX, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- According to DataM Intelligence, the next generation antibody therapeutics market size reached US ...
Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...
The rapid advancements in cancer immunotherapy have positioned bispecific antibodies (BsAbs) and T-cell engagers (TCEs) as transformative therapeutic strategies. However, the development of these ...
Antibody generation is a long and multi-step process, starting from antigen generation, immunization, screening to functional evaluation. There are multiple technology platforms available to support ...
Antibodies, in the most basic sense, are Y-shaped proteins that bind like a lock-and-key to a target. In the body, binding can trigger a cascade of actions that exterminate the invader. In the lab, ...
Invivyd reported Q4 2024 revenue of $13.8 million, highlighting significant growth and ongoing development of COVID-19 treatments PEMGARDA and VYD2311. Invivyd, Inc. reported a net product revenue of ...
- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results